Viewing Study NCT02866903


Ignite Creation Date: 2025-12-24 @ 7:19 PM
Ignite Modification Date: 2026-01-01 @ 3:34 PM
Study NCT ID: NCT02866903
Status: UNKNOWN
Last Update Posted: 2017-09-21
First Post: 2016-08-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety of Intraperitoneal (IP) OXAliplatin (OXA) in Association With Systemic FOLFIRI Bevacizumab Chemotherapy in Patients With Peritoneal Carcinosis
Sponsor: Hospices Civils de Lyon
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module